S-8 EX-FILING FEES 0001468492 Fees to be Paid N/A 0001468492 1 2026-08-24 2026-08-24 0001468492 2026-08-24 2026-08-24 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-8

HeartSciences Inc.

Table 1: Newly Registered Securities

                                       
Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                       
Equity   Common stock, $0.001 par value per share   (1)   Other   1,950,314   $ 2.4935   $ 4,863,107.96   0.0001381   $ 671.60
                                       
Total Offering Amounts:   $ 4,863,107.96         671.60
Total Fee Offsets:               0.00
Net Fee Due:             $ 671.60

 

__________________________________________
Offering Note(s)

(1) Calculated solely for purposes of this offering under Rules 457(c) and 457(h) of the Securities Act of 1933, as amended (the “Securities Act”), on the basis of the average of the high and low prices per share of Registrant’s Common Stock on Augst 20, 2026 as reported by The Nasdaq Stock Market.

Covers 1,289,000 shares of the Registrant’s common stock, $0.001 par value per share (“Common Stock”), included in the reoffer prospectus in Part I of the Registration Statement (the “Reoffer Prospectus”), which Reoffer Prospectus may be utilized for reofferings and resales by certain executive officers and directors of the Registrant listed in the Reoffer Prospectus who may be deemed “affiliates” of the Registrant on a continuous or a delayed basis in the future, which is inclusive of 794,000 shares of Common Stock issuable under the Registrant’s 2023 Equity Incentive Plan, as amended (the “Plan”). Pursuant to Rule 416 promulgated under the Securities Act, this registration statement shall also be deemed to cover any additional shares of Common Stock that may from time to time be offered or issued under the Plan to prevent dilution resulting from stock splits, stock dividends or similar transactions that increases the number of outstanding shares of Common Stock.